Having fought deadly breast cancer for close to a decade, Phloenphit Kowae’s life was hanging by a thread. The deadly disease had ravaged her body, starting from the breast and later spreading to her lungs, liver and bones. The reality was that she was terminally-ill and slowly dying.
However, Phloenphit did not envisage even in her wildest dreams that she would one day become part of a new groundbreaking immunotherapy treatment spearheaded by renowned physician Dr Kris Chatamra, honorary director and founder of the Queen Sirikit Centre for Breast Cancer (QSCBC) and his team of medical experts.
“I had nothing to lose by agreeing to this immunotherapy approach. Yes it was new and never tested before but it was also my last resort,” said the patient.
Dr Kris had offered Phloenphit the opportunity to become the first…
